by nobilistx | Mar 27, 2022 | Uncategorized |
Nobilis therapeutics is pleased to report that the validation formalities for the European patent it has licensed from MassGeneral Brigham have now been completed in France, Germany, Greece, Italy, the Netherlands, Portugal and the United Kingdom. The patent that has...
by nobilistx | Mar 27, 2022 | Uncategorized |
CCONNECTpreneur is one of the largest investor communities that has helped raise billions of dollars for startups and more established businesses. Nobilis Therapeutis is proud to be selected to present at this event and looks forward to sharing its...